161 related articles for article (PubMed ID: 19823927)
1. Levodopa influences the regularity of the ankle joint kinematics in individuals with Parkinson's disease.
Kurz MJ; Hou JG
J Comput Neurosci; 2010 Feb; 28(1):131-6. PubMed ID: 19823927
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder.
Morris M; Iansek R; McGinley J; Matyas T; Huxham F
Mov Disord; 2005 Jan; 20(1):40-50. PubMed ID: 15390033
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopaminergic therapy on locomotor adaptation and adaptive learning in persons with Parkinson's disease.
Roemmich RT; Hack N; Akbar U; Hass CJ
Behav Brain Res; 2014 Jul; 268():31-9. PubMed ID: 24698798
[TBL] [Abstract][Full Text] [Related]
4. Using ecological whole body kinematics to evaluate effects of medication adjustment in Parkinson disease.
Rahimi F; Bee C; Duval C; Boissy P; Edwards R; Jog M;
J Parkinsons Dis; 2014; 4(4):617-27. PubMed ID: 25055960
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease influences the structural variations present in the leg swing kinematics.
Ivkovic V; Kurz MJ
Motor Control; 2011 Jul; 15(3):359-75. PubMed ID: 21878689
[TBL] [Abstract][Full Text] [Related]
6. Locomotor response to levodopa in fluctuating Parkinson's disease.
Moore ST; MacDougall HG; Gracies JM; Ondo WG
Exp Brain Res; 2008 Feb; 184(4):469-78. PubMed ID: 17828529
[TBL] [Abstract][Full Text] [Related]
7. Hip, Knee, and Ankle Osteoarthritis Negatively Affects Mechanical Energy Exchange.
Queen RM; Sparling TL; Schmitt D
Clin Orthop Relat Res; 2016 Sep; 474(9):2055-63. PubMed ID: 27287859
[TBL] [Abstract][Full Text] [Related]
8. Levodopa changes brain motor network function during ankle movements in Parkinson's disease.
Schwingenschuh P; Katschnig P; Jehna M; Koegl-Wallner M; Seiler S; Wenzel K; Ropele S; Langkammer C; Gattringer T; Svehlík M; Ott E; Fazekas F; Schmidt R; Enzinger C
J Neural Transm (Vienna); 2013 Mar; 120(3):423-33. PubMed ID: 22990677
[TBL] [Abstract][Full Text] [Related]
9. Effects of aging and Parkinson's disease on joint coupling, symmetry, complexity and variability of lower limb movements during gait.
Park K; Roemmich RT; Elrod JM; Hass CJ; Hsiao-Wecksler ET
Clin Biomech (Bristol, Avon); 2016 Mar; 33():92-97. PubMed ID: 26963709
[TBL] [Abstract][Full Text] [Related]
10. Diurnal motor variations to repeated doses of levodopa in Parkinson's disease.
Bonuccelli U; Del Dotto P; Lucetti C; Petrozzi L; Bernardini S; Gambaccini G; Rossi G; Piccini P
Clin Neuropharmacol; 2000; 23(1):28-33. PubMed ID: 10682228
[TBL] [Abstract][Full Text] [Related]
11. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
[TBL] [Abstract][Full Text] [Related]
12. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
[TBL] [Abstract][Full Text] [Related]
13. Gait analysis in advanced Parkinson's disease--effect of levodopa and tolcapone.
Shan DE; Lee SJ; Chao LY; Yeh SI
Can J Neurol Sci; 2001 Feb; 28(1):70-5. PubMed ID: 11252300
[TBL] [Abstract][Full Text] [Related]
14. Levodopa and the progression of Parkinson's disease.
Walton-Hadlock JL
N Engl J Med; 2005 Mar; 352(13):1386; author reply 1386. PubMed ID: 15800240
[No Abstract] [Full Text] [Related]
15. Gait variability in Parkinson's disease: influence of walking speed and dopaminergic treatment.
Bryant MS; Rintala DH; Hou JG; Charness AL; Fernandez AL; Collins RL; Baker J; Lai EC; Protas EJ
Neurol Res; 2011 Nov; 33(9):959-64. PubMed ID: 22080998
[TBL] [Abstract][Full Text] [Related]
16. Effects of dopamine replacement therapy on lower extremity kinetics and kinematics during a rapid force production task in persons with Parkinson disease.
Foreman KB; Singer ML; Addison O; Marcus RL; LaStayo PC; Dibble LE
Gait Posture; 2014; 39(1):638-40. PubMed ID: 23968974
[TBL] [Abstract][Full Text] [Related]
17. Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease.
Bastian AJ; Kelly VE; Perlmutter JS; Mink JW
Mov Disord; 2003 Sep; 18(9):1008-17. PubMed ID: 14502668
[TBL] [Abstract][Full Text] [Related]
18. Gait variability in Parkinson's disease: levodopa and walking direction.
Bryant MS; Rintala DH; Hou JG; Collins RL; Protas EJ
Acta Neurol Scand; 2016 Jul; 134(1):83-6. PubMed ID: 26399376
[TBL] [Abstract][Full Text] [Related]
19. It's all in the type of the task: Dopamine modulates kinematic patterns during competitive vs. cooperative interaction in Parkinson's disease.
Straulino E; Scaravilli T; Bulgheroni M; D'Amico E; Castiello U
Neuropsychologia; 2016 Dec; 93(Pt A):106-115. PubMed ID: 27756693
[TBL] [Abstract][Full Text] [Related]
20. Jaw movement dysfunction related to Parkinson's disease and partially modified by levodopa.
Robertson LT; Hammerstad JP
J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):41-50. PubMed ID: 8558149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
